NPI registry status
Active
2026 NPPES data Pharmacist NPI 1144791435 RPH
Verify on CMS → Michael Padilla, RPH
Pharmacist in Ruidoso, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 291,043 in Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
531
Medicare Part D claims · 90 beneficiaries · Pharmacist avg: 135
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Michael Padilla, RPH filed 531 Medicare Part D claims in 2023 as a Pharmacist in Ruidoso, New Mexico, prescribing 68% generic.
- 531
- Part D claims, 2023
- 68%
- generic prescribing
- ≥66th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michael Padilla, RPH
Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1144791435), first enumerated 12/11/2018.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 531 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1144791435 · Pharmacist
NPI-10 · ENUM-RECENT · TAX-MEGA · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1144791435
- ENUM-RECENT 2018
- TAX-MEGA 291K Pharmacist
- RX-LIGHT 531
- BOOK-LIGHT 1,991 in New Mexico
- PHOTO-ENUM Krunal Bhatt · 2018
Michael Padilla, RPH's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
531 ≥ 66th percentile 66% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Michael Padilla, RPH?
Quality data not reportedPrimary specialty
Pharmacist
Medicare Part D claims
531 293% vs specialty avg
Specialty distribution in New Mexico
How Pharmacist compares to other specialties among New Mexico providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1144791435 |
|---|---|
| Specialty | Pharmacist |
| Credentials | RPH |
| Gender | Male |
| NPI Issued | 12/11/2018 |
Brand vs generic prescribing mix · Above average
Michael Padilla, RPH - brand share 32.0%
Pharmacist average
32% brand-name claims vs 68% generic, on 531 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
531
Total Claims
$174K
Total Drug Cost
90
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,139
- Total Day Supply
- 33,828
- Brand vs Generic
- 32% brand / 68% generic
- Brand Drug Cost
- $168K
- Generic Drug Cost
- $6K
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 1.34
- Gender Split
- 46% female / 54% male
- Age Distribution
- <65: 11, 65-74: 37, 75-84: 31, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Padilla, RPH prescribes most
Top Medicare Part D drugs by claim count, 2023
- Warfarin Sodium
Warfarin Sodium
187 claims
- Metformin Hcl 32
Metformin Hcl
32 claims
- Glipizide 29
Glipizide
29 claims
- Pioglitazone Hcl 27
Pioglitazone Hcl
27 claims
- Metformin Hcl Er 23
Metformin Hcl Er
23 claims
- Jardiance 21
Jardiance
21 claims
- Trulicity 18
Trulicity
18 claims
- Lisinopril 12
Lisinopril
12 claims
| Drug | Claims |
|---|---|
| Warfarin Sodium | 187 |
| Metformin Hcl | 32 |
| Glipizide | 29 |
| Pioglitazone Hcl | 27 |
| Metformin Hcl Er Metformin Hcl | 23 |
| Jardiance Empagliflozin | 21 |
| Trulicity Dulaglutide | 18 |
| Lisinopril | 12 |
| Novolog Flexpen Insulin Aspart | 12 |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How Michael Padilla, RPH fits within the Pharmacist landscape nationally.
291,043
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider
Michael Padilla, RPH's 531 claims are above the specialty average of 135.
Nationwide Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Padilla, both outside New Mexico so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2018)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pharmacist Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Padilla.
One of 1,991 Pharmacist providers enrolled in New Mexico, 5 are shown here.
Dr. Carolyn Abante
RPH
Santa Fe, NM
Dr. Mahmoud Abdelhaq
PHARMD
Albuquerque, NM
Dr. Jennifer Abernathy
PHARM.D.
Albuquerque, NM
Dr. Sandra Abeyta
RPH
Albuquerque, NM
Dr. Robin Abraham
PHARMD
Albuquerque, NM
Compare Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Michael Padilla, RPH's specialty? ▼
Michael Padilla, RPH specializes in Pharmacist and practices in Ruidoso, New Mexico. Credentials: RPH.
How much does Michael Padilla, RPH prescribe under Medicare Part D? ▼
In 2023, Michael Padilla, RPH wrote 531 Medicare Part D claims totaling $174K in drug costs for 90 beneficiaries.
Where is Michael Padilla, RPH located? ▼
Michael Padilla, RPH is located at 211 SUDDERTH DR, Ruidoso, NM, 88345. Phone: (575) 257-8264.
What is Michael Padilla, RPH's NPI number? ▼
Michael Padilla, RPH's National Provider Identifier (NPI) is 1144791435, issued on 12/11/2018.
Does Michael Padilla, RPH prescribe more brand-name or generic drugs? ▼
Michael Padilla, RPH's prescribing is 32% brand-name and 68% generic drugs by claim count, with $168K in brand drug costs.
How many Pharmacist providers are there in the US? ▼
There are 291,043 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does Michael Padilla, RPH prescribe most often? ▼
Based on 2023 Medicare Part D data, Michael Padilla, RPH's most frequently prescribed drugs include Warfarin Sodium, Metformin Hcl, Glipizide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Padilla, RPH accept Medicare? ▼
Michael Padilla, RPH appears in CMS Medicare data with 531 Part D claims and 90 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Padilla, RPH's credentials? ▼
Michael Padilla, RPH's NPI is 1144791435 with credentials RPH. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.